Related Experiment Videos
Factor VIII inhibitor associated with hepatocellular carcinoma
R F Neilson1, I D Walker, M Robertson
1Department of Haematology, Glasgow Royal Infirmary, UK.
Clinical and Laboratory Haematology
|January 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Heart Failure Optimization Study (HF-OPT): rationale and design.
Herzschrittmachertherapie & Elektrophysiologie·2023
Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory.
Current fungal infection reports·2021
A systematic review of droplet and aerosol generation in dentistry.
Journal of dentistry·2020
Child Caries Management: A Randomized Controlled Trial in Dental Practice.
Journal of dental research·2019
Cystic fibrosis presenting with haematological abnormalities.
Clinical and laboratory haematology·2006
T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
Clinical and laboratory haematology·2006
Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support.
Clinical and laboratory haematology·2006
Characterization of several amino acid transports and glutamine metabolism in MOLT4 human T4 leukemia cells.
Clinical and laboratory haematology·2006
Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates: a comparative study focused on multiple myeloma.
Clinical and laboratory haematology·2006
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026